List of insiders holdings for ELI LILLY & Co:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| LILLY ENDOWMENT INC 10% Owner | 2024-10-23 17:17:34 | 96,891,978 0 | 96,891,978 | Form 13G |
| LECHLEITER JOHN C former director Director | 2017-12-13 15:09:59 | 436,161 552,256 | 988,417 | Form 4 |
| Ricks David A President, Chair, and CEO | 2024-08-21 16:15:10 | 469,824 135,354 | 605,178 | Form 4 |
| WATANABE AUGUST M Former EVP, Science and Tech. | 2004-02-17 12:40:57 | 498,149 4,434 | 502,583 | Form 5 |
| Rice Derica W EVP-Global Services and CFO | 2018-01-30 16:10:15 | 0 405,432 | 405,432 | Form 5 |
| TAUREL SIDNEY Chairman | 2009-01-09 15:28:17 | 341,806 0 | 341,806 | Form 4/A |
| Lundberg Jan M EVP,Science&Tech and Pres. LRL | 2018-02-13 10:47:54 | 205,997 1,086 | 207,083 | Form 4 |
| GRANADILLO PEDRO P Senior Vice President | 2005-02-14 18:49:41 | 106,316 98,154 | 204,470 | Form 5 |
| Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm | 2024-09-12 16:16:25 | 117,903 75,616 | 193,519 | Form 4 |
| Fry Stephen F SVP, HR & Diversity | 2022-02-11 18:06:13 | 159,895 181 | 160,076 | Form 4 |
| Conterno Enrique A SVP&Pres, LillyDiab & LillyUSA | 2019-02-20 15:43:35 | 157,962 0 | 157,962 | Form 4/A |
| ARMITAGE ROBERT A Sr. VP and General Counsel | 2013-02-04 16:37:12 | 2,337 131,952 | 134,289 | Form 5 |
| Simmons Jeffrey N SVP&Pres. Elanco Animal Health | 2019-02-01 14:09:00 | 132,258 1,093 | 133,351 | Form 5 |
| MAYR GERHARD N EVP, Pharmaceutical Operations | 2004-02-19 14:02:54 | 120,000 0 | 120,000 | Form 4 |
| SANTINI GINO Sr.VP, Corp. Strategy & BD | 2010-02-03 12:27:33 | 96,495 19,394 | 115,889 | Form 5 |
| Crowe Maria A President, Mfg. Operations | 2018-01-30 16:06:54 | 111,517 0 | 111,517 | Form 5 |
| Peterson Barton R Sr. VP, Corp. Affairs & Comm. | 2017-02-03 15:11:07 | 108,312 1,560 | 109,872 | Form 4 |
| Walsh Fionnuala M SVP, Global Quality | 2017-02-03 15:18:14 | 67,144 42,357 | 109,501 | Form 4 |
| Harrington Michael J Senior VP and General Counsel | 2020-01-06 17:01:12 | 49,408 59,952 | 109,360 | Form 4 |
| GOLDEN CHARLES E Exec. Vice President and CFO | 2006-05-02 12:43:08 | 85,249 22,956 | 108,205 | Form 4 |
| O'Neill Myles SVP & Pres., Mfg. Operations | 2021-02-10 20:37:39 | 81,098 10,390 | 91,488 | Form 4 |
| Tapiero Jacques SVP&Pres., Emerging Markets | 2014-01-30 20:31:44 | 65,877 21,034 | 86,911 | Form 4 |
| Smiley Joshua L Former Officer | 2021-02-10 20:46:56 | 77,659 2,151 | 79,810 | Form 4 |
| SEIFERT KATHI P Director | 2020-11-18 21:25:49 | 77,038 0 | 77,038 | Form 4 |
| HORN KAREN N Director | 2015-12-02 15:18:03 | 73,166 0 | 73,166 | Form 4 |
| Fyrwald J Erik Director | 2024-11-20 16:22:44 | 72,541 0 | 72,541 | Form 4 |
| Zulueta Alfonso G SVP & President, Lilly Int'l | 2021-02-10 20:53:39 | 67,653 4,667 | 72,320 | Form 4 |
| White Anne E. EVP & Pres, Lilly Neuroscience | 2024-02-14 16:44:44 | 68,838 0 | 68,838 | Form 4 |
| PRENDERGAST FRANKLYN G Director | 2017-11-22 10:02:50 | 68,574 0 | 68,574 | Form 4 |
| TALLARIGO LORENZO President, Internat'l Opers. | 2008-04-02 15:13:41 | 64,458 2,153 | 66,611 | Form 4 |
| TAI JACKSON P Director | 2023-04-19 16:34:39 | 63,524 0 | 63,524 | Form 4 |
| Murphy Anthony John Senior VP, Human Resources | 2009-02-12 11:30:54 | 21,574 39,661 | 61,235 | Form 5 |
| Carmine Bryce D. EVP and Pres, Lilly Bio-Meds | 2012-02-16 15:00:25 | 51,186 6,869 | 58,055 | Form 5 |
| MARRAM ELLEN R Director | 2019-04-17 15:41:39 | 56,645 0 | 56,645 | Form 4 |
| Alvarez Ralph Director | 2024-12-17 16:16:26 | 54,689 0 | 54,689 | Form 4 |
| Jonsson Patrik EVP&Pres, LLY Dia&Obe, LLY USA | 2024-02-14 16:25:31 | 48,016 537 | 48,553 | Form 4 |
| GILMAN ALFRED G Director | 2013-12-03 15:36:30 | 48,287 0 | 48,287 | Form 4 |
| Ashkenazi Anat EVP & CFO | 2024-02-14 16:38:23 | 47,234 190 | 47,424 | Form 4 |
| ESKEW MICHAEL L Director | 2021-11-17 17:23:44 | 45,080 0 | 45,080 | Form 4 |
| PAUL STEVEN M EVP, Science and Technology | 2010-02-03 12:21:50 | 5,000 38,895 | 43,895 | Form 5 |
| Mason Michael B EVP & Pres., Lilly Diabetes | 2023-02-14 16:49:07 | 42,774 957 | 43,731 | Form 4 |
| BISCHOFF WINFRIED F W SIR Director | 2013-12-03 15:32:40 | 42,444 0 | 42,444 | Form 4 |
| Mahony Susan SVP & Pres., Lilly Oncology | 2019-02-01 14:38:13 | 40,685 0 | 40,685 | Form 4/A |
| Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM | 2021-02-10 20:29:50 | 38,630 927 | 39,557 | Form 4 |
| Shah Aarti S. SVP & CIDO | 2021-02-10 20:43:07 | 36,172 2,973 | 39,145 | Form 4 |
| HOOVER R DAVID Director | 2017-11-22 11:41:25 | 36,284 1,500 | 37,784 | Form 4 |
| Deane Frank M President, Mfg. Operations | 2012-02-02 15:43:34 | 33,995 2,519 | 36,514 | Form 4 |
| Canute Scott A President, Mfg. Operations | 2007-02-12 15:06:59 | 11,680 24,013 | 35,693 | Form 5 |
| Pusey Leigh Ann EVP, Corp. Affairs & Comm. | 2023-02-14 16:55:53 | 33,385 0 | 33,385 | Form 4 |
| Hernandez Edgardo EVP & Pres., Mfg. Operations | 2024-11-05 16:14:15 | 30,618 865.22 | 31,483 | Form 4 |
| FELDSTEIN MARTIN S Director | 2011-12-01 13:29:08 | 30,733 0 | 30,733 | Form 4 |
| Hakim Anat EVP, GC & Secretary | 2024-08-13 16:19:10 | 15,779 14,700 | 30,479 | Form 4 |
| Nobles Anne Chief Eth/Cmpl Ofcr & SVP, ERM | 2013-02-04 16:38:27 | 23,247 6,827 | 30,074 | Form 5 |
| FISHER GEORGE M C Director | 2008-05-02 11:30:07 | 28,942 0 | 28,942 | Form 4 |
| BEERING STEVEN C Director | 2004-12-02 09:23:50 | 27,760 0 | 27,760 | Form 4 |
| Norton Johna EVP, Global Quality | 2024-06-03 16:14:23 | 25,428 2,300 | 27,728 | Form 4 |
| HANISH ARNOLD C Chief Accounting Officer | 2012-10-30 09:46:17 | 17,611 8,590 | 26,201 | Form 4 |
| Connelly Deirdre P President, U.S. Operations | 2009-01-29 17:36:55 | 25,625 0 | 25,625 | Form 4 |
| Brooks Gordon J. Interim CFO, Group VP | 2024-07-19 16:16:12 | 21,365 3,694 | 25,059 | Form 3 |
| Baicker Katherine Director | 2024-11-20 16:21:02 | 23,118 0 | 23,118 | Form 4 |
| Yuffa Ilya EVP & President, LLY Int'l | 2024-02-14 16:29:27 | 23,071 0 | 23,071 | Form 4 |
| OBERHELMAN DOUGLAS R Director | 2014-12-02 16:01:51 | 22,675 0 | 22,675 | Form 4 |
| Kaelin William G Jr Director | 2024-11-20 16:26:56 | 21,465 0 | 21,465 | Form 4 |
| Van Naarden Jacob EVP & Pres., Lilly Oncology | 2024-11-01 16:17:41 | 11,845 8,644 | 20,489 | Form 4 |
| COOK J MICHAEL Director | 2008-12-02 15:47:18 | 17,337 0 | 17,337 | Form 4 |
| Azar Alex M II Sr. VP, Corp. Affairs & Comm. | 2009-01-29 17:32:55 | 17,084 0 | 17,084 | Form 4 |
| Runge Marschall S Director | 2023-11-21 16:29:03 | 16,593 0 | 16,593 | Form 4 |
| LUCIANO JUAN R Director | 2024-12-17 16:21:44 | 16,191 0 | 16,191 | Form 4 |
| Rau Diogo EVP & CIDO | 2024-06-04 16:14:28 | 11,101 0 | 11,101 | Form 4 |
| Montarce Lucas EVP & CFO | 2024-11-05 16:15:32 | 11,074 0 | 11,074 | Form 4 |
| JACKSON JAMERE Director | 2024-11-20 16:24:54 | 9,154 0 | 9,154 | Form 4 |
| Weems Alonzo EVP, ERM & CECO | 2024-02-14 16:21:39 | 8,931 0 | 8,931 | Form 4 |
| Dozier Eric EVP, HR & Diversity | 2024-11-05 16:13:14 | 8,043 291.66 | 8,334 | Form 4 |
| Zakrowski Donald A SVP, Finance, & CAO | 2024-11-08 16:18:15 | 5,480 1,716 | 7,196 | Form 4 |
| Walker Karen Director | 2024-11-20 16:29:51 | 6,249 0 | 6,249 | Form 4 |
| Bertozzi Carolyn R Director | 2020-11-18 21:24:14 | 6,243 0 | 6,243 | Form 4 |
| JOHNSON KIMBERLY H Director | 2024-12-17 16:19:33 | 3,032 0 | 3,032 | Form 4 |
| Seymour Melissa EVP, Global Quality | 2024-08-02 16:03:26 | 2,885 0 | 2,885 | Form 4 |
| Sulzberger Gabrielle Director | 2024-12-17 16:23:10 | 2,533 0 | 2,533 | Form 4 |
| Hedley Mary Lynne Director | 2024-12-17 16:17:56 | 1,879 98 | 1,977 | Form 4 |
| ROSE JOHN SIR Director | 2005-01-03 16:30:35 | 1,689 0 | 1,689 | Form 4 |
| Shaw Christi SVP and Pres., Lilly Bio-Meds | 2019-05-16 16:44:23 | 500 0 | 500 | Form 4/A |
| Moeller Jon R Director | 2024-12-04 16:20:01 | 71 0 | 71 | Form 3 |
| Johnson John H Sr. VP, Oncology Business Unit | 2009-11-10 12:38:55 | 0 0 | 0 | Form 3 |